flotetuzumab
Showing 1 - 4 of 4
Leukemia, Myeloid, Acute Trial in Baltimore (Flotetuzumab)
Not yet recruiting
- Leukemia, Myeloid, Acute
- Flotetuzumab
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Aug 16, 2022
Relapsed Acute Myeloid Leukemia Trial in Saint Louis (Flotetuzumab, Donor lymphocyte infusion)
Recruiting
- Relapsed Acute Myeloid Leukemia
- Flotetuzumab
- Donor lymphocyte infusion
-
Saint Louis, MissouriWashington University School of Medicine
Sep 7, 2022
AML Trial in Netherlands (Flotetuzumab)
Withdrawn
- AML
- Flotetuzumab
-
Amsterdam, Netherlands
- +3 more
Dec 20, 2021
Recurrent Acute Leukemia, Recurrent B Acute Lymphoblastic Leukemia, Recurrent Blastic Plasmacytoid Dendritic Cell Tumor Trial in
Recruiting
- Recurrent Acute Leukemia
- +16 more
- Acetaminophen
- +5 more
-
Duarte, CaliforniaCity of Hope Medical Center
Nov 22, 2022